EMERALIS Trademark (Class 5) — Opposed Status & Details

The current status of EMERALIS is "Opposed". It was filed on 24/05/2023 at CHENNAI in Class 5. Status may change over time as the application moves through examination, publication, opposition and registration stages.

EMERALIS is filed in Class 5, covering: Pharmaceuticals; Pharmaceutical preparations; Nutraceutical preparations for humans; Nutraceuticals for therapeutic purposes; Nutraceuticals for medical purposes; Nutraceutical preparations for human beings; Nutraceuticals for use as dietary supplements; Nutraceuticals for therapeutic or medical purposes; Nutraceutical preparations for therapeutic or medical purposes; Nutraceutical preparations for use as dietary supplements; Nutraceuticals for use as a dietary supplement; Transdermal patches that facilitate the delivery of nutraceuticals; Pharmaceutical drugs; Pharmaceutical substances; Pharmaceutical tablets; Pharmaceutical pastilles; Pharmaceutical lozenges; Pharmaceutical pills; Antibacterial pharmaceuticals; Cardiovascular pharmaceuticals; Homeopathic pharmaceuticals; Ocular pharmaceuticals; Antidiabetic pharmaceuticals; Pastilles [pharmaceuticals]; Lozenges [pharmaceuticals]; Pills [pharmaceuticals]; Tablets [pharmaceuticals]; Chemico pharmaceutical preparations; Elixirs [pharmaceutical preparations]; Pharmaceutical skin lotions; Cardiovascular pharmaceutical preparations; Topical pharmaceutical preparations; Pharmaceutical cough preparations; Pharmaceutical cold preparations; Antiepileptic pharmaceutical preparations; Antibacterial pharmaceutical preparations; Dermatological pharmaceutical preparations; Anti-diabetic pharmaceuticals; Pills being pharmaceuticals; Pastilles being pharmaceuticals; Lozenges being pharmaceuticals; Tablets being pharmaceuticals; Alcohol for pharmaceutical purposes; Aldehydes for pharmaceutical purposes; Syrups for pharmaceutical purposes; Decoctions for pharmaceutical purposes; Digestives for pharmaceutical purposes; Magnesia for pharmaceutical purposes; Eucalyptol for pharmaceutical purposes; Meal for pharmaceutical purposes; Peptones for pharmaceutical purposes; Lotions for pharmaceutical purposes; Mint for pharmaceutical purposes; Ointments for pharmaceutical purposes; Pectin for pharmaceutical purposes; Pepsins for pharmaceutical purposes; Phosphates for pharmaceutical purposes; Pharmaceutical preparations containing amino acids; Plant extracts for pharmaceutical use; Chemical preparations for pharmaceutical purposes; Pharmaceutical agents affecting sensoryorgans.

EMERALIS covers: Pharmaceuticals; Pharmaceutical preparations; Nutraceutical preparations for humans; Nutraceuticals for therapeutic purposes; Nutraceuticals for medical purposes; Nutraceutical preparations for human beings; Nutraceuticals for use as dietary supplements; Nutraceuticals for therapeutic or medical purposes; Nutraceutical preparations for therapeutic or medical purposes; Nutraceutical preparations for use as dietary supplements; Nutraceuticals for use as a dietary supplement; Transdermal patches that facilitate the delivery of nutraceuticals; Pharmaceutical drugs; Pharmaceutical substances; Pharmaceutical tablets; Pharmaceutical pastilles; Pharmaceutical lozenges; Pharmaceutical pills; Antibacterial pharmaceuticals; Cardiovascular pharmaceuticals; Homeopathic pharmaceuticals; Ocular pharmaceuticals; Antidiabetic pharmaceuticals; Pastilles [pharmaceuticals]; Lozenges [pharmaceuticals]; Pills [pharmaceuticals]; Tablets [pharmaceuticals]; Chemico pharmaceutical preparations; Elixirs [pharmaceutical preparations]; Pharmaceutical skin lotions; Cardiovascular pharmaceutical preparations; Topical pharmaceutical preparations; Pharmaceutical cough preparations; Pharmaceutical cold preparations; Antiepileptic pharmaceutical preparations; Antibacterial pharmaceutical preparations; Dermatological pharmaceutical preparations; Anti-diabetic pharmaceuticals; Pills being pharmaceuticals; Pastilles being pharmaceuticals; Lozenges being pharmaceuticals; Tablets being pharmaceuticals; Alcohol for pharmaceutical purposes; Aldehydes for pharmaceutical purposes; Syrups for pharmaceutical purposes; Decoctions for pharmaceutical purposes; Digestives for pharmaceutical purposes; Magnesia for pharmaceutical purposes; Eucalyptol for pharmaceutical purposes; Meal for pharmaceutical purposes; Peptones for pharmaceutical purposes; Lotions for pharmaceutical purposes; Mint for pharmaceutical purposes; Ointments for pharmaceutical purposes; Pectin for pharmaceutical purposes; Pepsins for pharmaceutical purposes; Phosphates for pharmaceutical purposes; Pharmaceutical preparations containing amino acids; Plant extracts for pharmaceutical use; Chemical preparations for pharmaceutical purposes; Pharmaceutical agents affecting sensoryorgans.

The exact word "EMERALIS" is already on record at the Indian Trademark Registry under Application No. 5950637. If you intend to use a similar mark for similar goods or services, you should conduct a comprehensive availability search and consult a trademark attorney before filing. Registerkaro offers a free availability check followed by professional filing.

Indian registered trademarks are valid for 10 years from the date of registration and can be renewed indefinitely in 10-year blocks. EMERALIS (App #5950637) is currently in status "Opposed" — renewal dates apply only after registration is granted.

If EMERALIS is in the "Advertised before Acceptance" or "Accepted & Advertised" stage, you have a 4-month window from publication in the Trade Marks Journal to file an opposition (Form TM-O) at the same Trade Marks Registry office. Grounds typically include prior rights, descriptiveness or bad faith. Registerkaro can prepare and file a Notice of Opposition for you.